Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions

Journal of Neuropathology and Experimental Neurology

Volumn 68, Issue 2, 2009, Pages 159-167

  Koning, Nathalie ^a,b   Swaab, Dick F ^a   Hoek, Robert M ^a,b   Huitinga, Inge ^a,c  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c NETHERLANDS BRAIN BANK   (Netherlands)

Author keywords

CD200 CD200R; Glia glia interaction; Immune inhibition; Immune privilege; Multiple sclerosis; Neuron glia interaction

Indexed keywords

CD200 ANTIGEN; CD200 RECEPTOR; ANTIGENS, CD200; BIOLOGICAL MARKER; CD200R1 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; LEUKOCYTE ANTIGEN; MEMBRANE ANTIGEN;

ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN CORTEX; CELL INTERACTION; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FLOW CYTOMETRY; GLIA CELL; GRAY MATTER; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; MACROPHAGE; MALE; MICROGLIA; MOLECULAR MECHANICS; MULTIPLE SCLEROSIS; NERVE CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPINAL CORD; WHITE MATTER; ANIMAL; BRAIN; CELL COMMUNICATION; GLIA; GLIOSIS; IMMUNOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, CD; ANTIGENS, SURFACE; ASTROCYTES; BIOLOGICAL MARKERS; BRAIN; CELL COMMUNICATION; CENTRAL NERVOUS SYSTEM; FEMALE; GLIOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICROGLIA; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROGLIA; NEURONS; RECEPTORS, CELL SURFACE; SPINAL CORD;

EID: 64049116317     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3181964113     Document Type: Article

References (30)

1. Galea I, Bechmann I, Perry VH. What is immune privilege (not)? Trends Immunol 2007;28:12-18
2. Hoek RM, Ruuls SR, Murphy CA, et al. Down-regulation of the mac-rophage lineage through interaction with OX2 (CD200). Science 2000; 290:1768-1771
3. Webb M, Barclay AN. Localisation of the MRC OX-2 glycoprotein on the surfaces of neurones. J Neurochem 1984;43:1061-1067
4. Wright GJ, Puklavec MJ, Willis AC, et al. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 2000;13:233-242
5. Wright GJ, Jones M, Puklavec MJ, et al. The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans. Immunology 2001;102:173-179
6. Rijkers ES, de Ruiter T, Baridi A, et al. The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytes. Mol Immunol 2008;45:1126-1135
7. Jenmalm MC, Cherwinski H, Bowman EP, et al. Regulation of myeloid cell function through the CD200 receptor. J Immunol 2006;176:191-199
8. Dick AD, Broderick C, Forrester JV, et al. Distribution of OX2 antigen and OX2 receptor within retina. Invest Ophthalmol Vis Sci 2001;42: 170-176
9. Zhang S, Cherwinski H, Sedgwick JD, et al. Molecular mechanisms of CD200 inhibition of mast cell activation. J Immunol 2004;173: 6786-6793
10. Broderick C, Hoek RM, Forrester JV, et al. Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am J Pathol 2002;161:1669-1677
11. Chitnis T, Imitola J, Wang Y, et al. Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegenera-tion. Am J Pathol 2007;170:1695-1712
12. Koning N, Bo L, Hoek RM, et al. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions. Ann Neurol 2007;62: 504-514
13. Wright GJ, Cherwinski H, Foster-Cuevas M, et al. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J Immunol 2003;171:3034-3046
14. Kerstens HM, Poddighe PJ, Hanselaar AG. A novel in situ hybridization signal amplification method based on the deposition of biotinylated ty-ramine. J Histochem Cytochem 1995;43:347-352
15. Bö L, Mork S, Kong PA, et al. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 1994;51:135-146
16. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-285
17. Van der Valk P, De Groot CJ. Staging of multiple sclerosis (MS) lesions: Pathology of the time frame of MS. Neuropathol Appl Neurobiol 2000; 26:2-10
18. Sedgwick JD, Schwender S, Imrich H, et al. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci U S A 1991;88:7438-7442
19. Deckert M, Sedgwick JD, Fischer E, et al. Regulation of microglial cell responses in murine Toxoplasma encephalitis by CD200/CD200 receptor interaction. Acta Neuropathol (Berl) 2006;111:548-558
20. Galea I, Palin K, Newman TA, et al. Mannose receptor expression specifically reveals perivascular macrophages in normal, injured, and diseased mouse brain. Glia 2005;49:375-384
21. McCaughan GW, Clark MJ, Barclay AN. Characterization of the human homolog of the rat MRC OX-2 membrane glycoprotein. Immunogenetics 1987;25:329-335
22. Benowitz LI, Apostolides PJ, Perrone-Bizzozero N, et al. Anatomical distribution of the growth-associated protein GAP-43/B-50 in the adult rat brain. J Neurosci 1988;8:339-352
23. Teunissen CE, Dijkstra CD, Jasperse B, et al. Growth-associated protein 43 in lesions and cerebrospinal fluid in multiple sclerosis. Neuropathol Appl Neurobiol 2006;32:318-331
24. Huitinga I, Van Rooijen N, De Groot CJ, et al. Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 1990;172:1025-1033
25. Meuth SG, Simon OJ, Grimm A, et al. CNS inflammation and neuronal degeneration is aggravated by impaired CD200-CD200RYmediated mac-rophage silencing. J Neuroimmunol 2008;194:62-69
26. Takuma K, Baba A, Matsuda T. Astrocyte apoptosis: Implications for neuroprotection. Prog Neurobiol 2004;72:111-127
27. Elward K, Gasque P. BEat me[ and Bdon't eat me[ signals govern the innate immune response and tissue repair in the CNS: Emphasis on the critical role of the complement system. Mol Immunol 2003;40:85-94
28. Griffiths M, Neal JW, Gasque P. Innate immunity and protective neuroinflammation: New emphasis on the role of neuroimmune regulatory proteins. Int Rev Neurobiol 2007;82:29-55
29. Rogers J, Mastroeni D, Leonard B, et al. Neuroinflammation in Alzheimer's disease and Parkinson's disease: Are microglia pathogenic in either disorder? Int Rev Neurobiol 2007;82:235-246
30. Simi A, Tsakiri N, Wang P, et al. Interleukin-1 and inflammatory neurodegeneration. Biochem Soc Trans 2007;35:1122-1126